Results 171 to 180 of about 30,706 (198)
Some of the next articles are maybe not open access.
Journal of Oncology Pharmacy Practice
Introduction Adherence and toxicity symptoms ideally are monitored within 7–14 days after initiating oral anticancer medication (OAM). After implementing a formal OAM program at our institution, we found our adherence and toxicity monitoring was suboptimal and sought to improve our processes to reduce patient risk, using a ...
Lisa M Holle +4 more
openaire +2 more sources
Introduction Adherence and toxicity symptoms ideally are monitored within 7–14 days after initiating oral anticancer medication (OAM). After implementing a formal OAM program at our institution, we found our adherence and toxicity monitoring was suboptimal and sought to improve our processes to reduce patient risk, using a ...
Lisa M Holle +4 more
openaire +2 more sources
Discarded Targeted Oral Anticancer Medication—A Hard Pill to Swallow?
JAMA Oncology, 2023Cathy J. Bradley +2 more
openaire +1 more source
American Journal of Health-System Pharmacy
Abstract Purpose To evaluate the implementation of an electronic early treatment assessment and monitoring (eTEAM) questionnaire within the electronic health record (EHR) patient portal designed to identify early adverse effects to oral anticancer therapy requiring pharmacist intervention.
Tiffany Bui +7 more
openaire +2 more sources
Abstract Purpose To evaluate the implementation of an electronic early treatment assessment and monitoring (eTEAM) questionnaire within the electronic health record (EHR) patient portal designed to identify early adverse effects to oral anticancer therapy requiring pharmacist intervention.
Tiffany Bui +7 more
openaire +2 more sources
Journal of Oncology Pharmacy Practice
Introduction A growing number of patients with breast cancer use oral anticancer medications (OAMs) but may face barriers in managing their therapy at home, potentially impacting their treatment outcomes. Understanding these barriers is essential to designing effective interventions.
Yejin Seo +5 more
openaire +2 more sources
Introduction A growing number of patients with breast cancer use oral anticancer medications (OAMs) but may face barriers in managing their therapy at home, potentially impacting their treatment outcomes. Understanding these barriers is essential to designing effective interventions.
Yejin Seo +5 more
openaire +2 more sources
UNSTRUCTURED Adherence to prescribed oral anticancer therapy is an important determinant of patient outcomes, including progression-free and overall survival. While many factors (eg, medication side effects and out-of-pocket costs, problems with insurance authorization, and timely medication refills) can ...
Mahtab Jafari +3 more
openaire +1 more source
Mahtab Jafari +3 more
openaire +1 more source
Drug Supply Chain Security Act and Oral Anticancer Medications
JAMA Oncology, 2016Daniel M, Geynisman, Yu-Ning, Wong
openaire +2 more sources
Standardizing Oral Anticancer Medication Initiation to Improve Clinician Compliance with National Guidelines (Under the direction of Tracy Vernon-Platt) The aim of this quality improvement project was to standardize the process for initiating oral anticancer medications (OAMs) to align ...
openaire +1 more source
openaire +1 more source
Oral complications of cancer and cancer therapy
Ca-A Cancer Journal for Clinicians, 2012Joel B Epstein +2 more
exaly
Oral cavity and oropharyngeal squamous cell carcinoma—an update
Ca-A Cancer Journal for Clinicians, 2015Angela C Chi
exaly